EUVIMEDEUVIMED entdecken
Crossref

Lipopolysaccharide-Induced Depression-Like Behaviors Is Ameliorated by Sodium Butyrate via Inhibiting Neuroinflammation and Oxido-Nitrosative Stress

Jian Qiu, Renjie Liu, Yaoying Ma, Yan Li, Zhuo Chen, Haiyan He, Jinliang Chen, Lijuan Tong, Chao Huang, Qingsheng You

Pharmacology · 2020 · 105 (9-10) · 550-560

DOI: 10.1159/000505132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology, online erschienen am 23.03.2020. Verfasst von Jian Qiu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, China. Die Arbeit wurde bisher 60-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is a common disease that afflicts one in 6 people. Numerous hypotheses have been raised in the past decades, but the exact mechanism for depression onset remains obscure. Recently, the neuroinflammatory response and oxidative stress are being attracted more and more attention due to their roles in depression pathogenesis. The inhibition of neuroinflammatory response and oxidative stress is now considered a potential strategy for depression prevention and/or therapy. Sodium butyrate (SB) is a sodium form of the endogenous butyrate. It can inhibit proinflammatory responses and oxidative stress in different models of disease. In the present study, we investigated the effect of SB on lipopolysaccharide (LPS)-induced depression-like behaviors, neuroinflammatory response, and oxido-nitrosative stress in the hippocampus and prefrontal cortex in C57BL6/J mice. Our results showed that 10 days of SB pretreatment at the dose of 300 but not 100 mg/kg markedly ameliorated LPS (0.83 mg/kg)-induced depression-like behaviors in the tail suspension test, forced swimming test, and sucrose preference test. Further analysis showed that 10 days of SB pretreatment not only prevented LPS-induced increases in proinflammatory cytokines, such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α, in the hippocampus and prefrontal cortex but also prevented LPS-induced enhancement of oxido-nitrosative stress. Taken together, these results demonstrate that SB is such an agent that could be used to prevent depression onset and/or progression, and inhibition of neuroinflammatory response and oxido-nitrosative stress may be a potential mechanism for its antidepressant actions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntidepressive AgentsBehavior, AnimalButyric AcidCytokinesDepressionDisease Models, AnimalHindlimb SuspensionHippocampusInflammationLipopolysaccharidesMaleMiceMice, Inbred C57BLNitrosative StressOxidative StressPhysical Conditioning, AnimalPrefrontal CortexSwimming

Stichwörter der Autor:innen

DepressionLipopolysaccharideNeuroinflammationOxidative stressSodium butyrate

Substanzen

Antidepressive AgentsCytokinesLipopolysaccharidesButyric Acid

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
  • Department of Pharmacology, School of Pharmacy, Nantong University, Nantong, China.
  • Department of Invasive Technology, Nantong First People's Hospital, The Second Affiliated Hospital of Nantong University, Nantong, China.
  • Department of Respiratory Medicine, The Second Affiliated Hospital of Nantong University, Nantong, China.
  • Department of Pharmacology, School of Pharmacy, Nantong University, Nantong, China, asicampa@aliyun.com.

Zitieren

APA

Qiu, J., Liu, R., Ma, Y., Li, Y., Chen, Z., He, H., Chen, J., Tong, L., Huang, C., & You, Q. (2020). Lipopolysaccharide-Induced Depression-Like Behaviors Is Ameliorated by Sodium Butyrate via Inhibiting Neuroinflammation and Oxido-Nitrosative Stress. Pharmacology, 105(9-10), 550-560. https://doi.org/10.1159/000505132

Vancouver

Qiu J, Liu R, Ma Y, Li Y, Chen Z, He H, et al. Lipopolysaccharide-Induced Depression-Like Behaviors Is Ameliorated by Sodium Butyrate via Inhibiting Neuroinflammation and Oxido-Nitrosative Stress. Pharmacology. 2020;105(9-10):550-560. doi:10.1159/000505132

BibTeX
@article{Qiu2020,
  author = {Qiu, Jian and Liu, Renjie and Ma, Yaoying and Li, Yan and Chen, Zhuo and He, Haiyan and Chen, Jinliang and Tong, Lijuan and Huang, Chao and You, Qingsheng},
  title = {Lipopolysaccharide-Induced Depression-Like Behaviors Is Ameliorated by Sodium Butyrate via Inhibiting Neuroinflammation and Oxido-Nitrosative Stress},
  journal = {Pharmacology},
  year = {2020},
  volume = {105},
  number = {9-10},
  pages = {550--560},
  doi = {10.1159/000505132}
}
Kostenlos starten →